Legal Opinion
United States Ex Rel. Ge v. Takeda Pharmaceutical Co.
Court of Appeals for the First Circuit
Decided December 6, 2013No. 13-1088, 13-1089PublishedCited by 100 opinions
1Opinion of the Court
LYNCH, Chief Judge.
In June 2010 Dr. Helen Ge originally filed these two qui tam actions against her former employer, Takeda Pharmaceutical Company Ltd. and its subsidiary Takeda Pharmaceutical North America, Inc. (collectively, “Takeda”), under the federal False Claims Act (“FCA”), 31 U.S.C. § 3729 et seq., and various analogous state statutes. The two actions concern different drugs. She has since amended each of her complaints twice. The United States has declined to enter the case as a party. In a successful qui tam action, the relator collects a portion of the award to the government…
2Cases cited36 opinions
- Foman v. DavisSupreme Court of the United States · 1962
- United States v. Ilario M.A. ZanninoCourt of Appeals for the First Circuit · 1990
- Rodi v. Southern New England School of LawCourt of Appeals for the First Circuit · 2004
- Palmer v. Champion MortgageCourt of Appeals for the First Circuit · 2006
- United States Ex Rel. Clausen v. Laboratory Corp. of America, Inc.Court of Appeals for the Eleventh Circuit · 2002
31 more not listed; retrieve them via the Exa API.
3Cited by100 opinions
- Mancini v. City of ProvidenceCourt of Appeals for the First Circuit · 2018
- Dumont v. Reily Foods Co.Court of Appeals for the First Circuit · 2019
- Hagerty Ex Rel. United States v. Cyberonics, Inc.Court of Appeals for the First Circuit · 2016
- D'Agostino v. EV3, Inc.Court of Appeals for the First Circuit · 2016
- United States Ex Rel. Booker v. Pfizer, Inc.Court of Appeals for the First Circuit · 2017
95 more not listed; retrieve them via the Exa API.